Learn / History

A Short History of Medical Cannabis Access and Online Evaluations

From ancient apothecaries to prohibition to today's video-call visits, medical-cannabis access has traveled a long road. Here is the broad arc — and how remote evaluations became part of it.

Few plants have traveled a stranger road through medicine than cannabis. It has been a pharmacy staple, a forbidden substance, and — more recently — the subject of state-by-state legal programs that let approved patients use it under a clinician's guidance. Understanding how that access evolved makes the modern landscape far easier to navigate, whether you are simply curious or trying to make sense of terms like "recommendation," "card," and "online evaluation." This guide traces the broad arc, from ancient apothecaries to the video-call consultations that became common in the last decade.

Medicine long before regulation

Cannabis appears in some of the oldest surviving medical writings. References to its use turn up in ancient Chinese, Indian, Egyptian, and Greek texts, where preparations were described for pain, cramps, sleep, and other complaints. For most of recorded history the plant was treated as an ordinary botanical remedy — no different in principle from willow bark or opium poppy.

That status carried into the modern era. Through the nineteenth and early twentieth centuries, cannabis extracts were listed in Western pharmacopeias and sold by pharmacists as tinctures. Dosing was imprecise and the science was thin by today's standards, but the plant was a legitimate, if minor, part of the medicine cabinet.

The prohibition century

The picture changed sharply in the twentieth century. A wave of restrictions, tax measures, and eventually outright prohibition pushed cannabis out of mainstream medicine across much of the world. By mid-century it had been reclassified in many places as a controlled substance with, officially, no accepted medical use.

Prohibition did more than remove the plant from pharmacy shelves. It also froze research for decades, because studying a tightly controlled substance is difficult and slow. The result was a long gap in which anecdote outpaced formal evidence — a gap that still shapes debates about cannabis today, and one reason patient-facing education tends to emphasize caution and individualized medical judgment.

A patient-led revival

The modern medical-cannabis era began not in a laboratory but at the ballot box. In 1996, California voters approved a measure allowing patients to use cannabis with a physician's approval — the first such state program in the United States. Other states followed over the next two decades, each writing its own list of eligible conditions, its own registration process, and its own rules for possession and cultivation.

One legal subtlety shaped everything that came after. Because cannabis remained federally controlled, clinicians could not write a conventional prescription for it the way they would for a pharmacy drug. Instead, state programs relied on a physician's recommendation — a documented professional opinion that a patient might benefit — which the state then translated into eligibility. If you have ever wondered why people talk about a "recommendation" rather than a prescription, this is the reason. Our overview of medical cannabis card basics walks through how that recommendation becomes an actual registration or card.

How access came to be structured

As programs matured, a common shape emerged even though the details varied widely from state to state. Most systems settled on a handful of shared elements:

• Qualifying conditions. Each program publishes a list of health conditions considered eligible. These lists differ significantly by jurisdiction — see our overview of qualifying conditions for how they are typically organized.
• A clinical evaluation. A licensed clinician reviews the patient's history and situation before issuing a recommendation. We describe the general flow in how medical cannabis evaluations work.
• State registration. Approved patients typically enroll with a state registry, often receiving a card or digital credential that confirms their status.
• Ongoing renewal. Recommendations and registrations usually expire and must be renewed, keeping a clinician involved over time.

None of this is the same as the recreational-cannabis laws that later appeared in some places. Medical programs are built around a clinician's involvement and a documented condition, which is a meaningfully different framework from adult-use retail.

The arrival of telemedicine

For most of the medical-cannabis era, the evaluation meant an in-person visit. That began to shift as telemedicine — clinical care delivered remotely by phone or video — moved from a niche convenience to an everyday expectation. Broadband, smartphones, and secure video tools made it practical for a patient and a clinician to meet without sharing a room, and a broad expansion of telehealth acceptance in the early 2020s accelerated the trend across many kinds of care.

Medical-cannabis evaluations fit this model unusually well. Much of the assessment is a conversation: reviewing history, discussing symptoms, and confirming eligibility. Where local rules permitted, some programs allowed part or all of the evaluation to happen over a live video call from the patient's own device, with no traditional appointment scheduling required. If the concept of a remote clinical visit is new to you, our primer on telemedicine basics for patients covers what to expect.

What online evaluations changed

Moving the evaluation online altered the experience in a few consistent ways. Convenience was the obvious one: a video visit removes travel and long waits, and can often be scheduled quickly. But two quieter shifts mattered just as much.

The first was privacy. Cannabis carries lingering stigma for many people, and a confidential, secure video session conducted from home can feel less exposing than a waiting room. Reputable remote-care setups emphasize that the session is private and that patient information is handled securely — the same expectations that apply to any telehealth encounter.

The second was access. Remote evaluations can reach patients who live far from a participating clinic, who have mobility limits, or whose schedules make an in-person visit difficult. That said, availability still depends entirely on local law: a remote evaluation is only meaningful where the jurisdiction recognizes it, and rules continue to change.

It is worth keeping cannabis distinct from hemp-derived products here, since the two are often confused. Widely sold CBD products differ from medical cannabis in their legal treatment and typically do not require any clinical evaluation at all.

Where things stand

Taken together, the history is one of a full circle with a modern twist. A plant that began as an ordinary remedy was pushed out of medicine for most of a century, then reintroduced through patient-driven state programs built on clinician recommendations rather than prescriptions. Telemedicine then reshaped how those recommendations are obtained, making the evaluation faster, more private, and more widely reachable — within whatever limits local law sets.

For anyone approaching the topic today, the practical takeaways are simple: access is governed by your specific jurisdiction, a licensed clinician's judgment sits at the center of the process, and the format of the visit — in person or by video — is a matter of convenience and local rules rather than a change in the underlying medicine. If a consultation is in your future, a little preparation goes a long way; our guide to preparing for a cannabis consultation covers what tends to be helpful to have ready.

Those who enjoy longer-form explainers on CBD, terpenes, and responsible use will find further reading in the cannabisshop guide.